Skip to main content

RxHighlights

A monthly overview of treatment guidelines, important literature and key issues influencing today’s pharmacy and health care environment.

June 2025

Core topics in this month’s edition include:

  • 0.9% Sodium Chloride Inj. - Drug Recall
  • Brukinsa® (zanubrutinib) – New formulation approval
  • Complera® (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) – First-time generic

Download

Rx navigation